Validation of the hellenicSCORE (A calibration of the ESC SCORE project) regarding 10-year risk of fatal cardiovascular disease in Greece

Hellenic Journal of Cardiology

Volumn 56, Issue 4, 2015, Pages 302-308

  Panagiotakos, Demosthenes B ^a   Georgousopoulou, Ekavi N ^a   Fitzgerald, Anthony P ^b   Pitsavos, Christos ^c   Stefanadis, Christodoulos ^c  

^a HAROKOPIO UNIVERSITY   (Greece)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cardiovascular disease; Risk prediction; Scores; Validation

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COMORBIDITY; DESCRIPTIVE RESEARCH; DISEASE ASSESSMENT; EUROPEAN SOCIETY OF CARDIOLOGY SCORE; FEMALE; FOLLOW UP; GREECE; HELLENICSCORE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; OUTCOME ASSESSMENT; RELIABILITY; RISK ASSESSMENT; SMOKING; SURVIVAL; SYSTOLIC BLOOD PRESSURE; VALIDATION PROCESS; CARDIOVASCULAR DISEASES; INCIDENCE; MIDDLE AGED; MORTALITY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; GREECE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK ASSESSMENT; YOUNG ADULT;

EID: 84939429195     PISSN: 11099666     EISSN: 22415955     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012; 33: 1635-1701.
2. Pyörälä K. Assessment of coronary heart disease risk in populations with different levels of risk. Eur Heart J. 2000; 21: 348-350.
3. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol. 1976; 38: 46-51.
4. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J. 2000; 21: 365-370.
5. Liao Y, McGee DL, Cooper RS, Sutkowski MB. How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts. Am Heart J. 1999; 137: 837-845.
6. Haq IU, Ramsay LE, Yeo WW, Jackson PR, Wallis EJ. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart. 1999; 81: 40-46.
7. Menotti A, Lanti M, Puddu PE, Kromhout D. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart. 2000; 84: 238-244.
8. Conroy RM, Pyörälä K, Fitzgerald AP, et al; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24: 987-1003.
9. Panagiotakos DB, Fitzgerald AP, Pitsavos C, Pipilis A, Graham I, Stefanadis C. Statistical modelling of 10-year fatal cardiovascular disease risk in Greece: the HellenicSCORE (a calibration of the ESC SCORE project). Hellenic J Cardiol. 2007; 48: 55-63.
10. Stefanadis CI. The HellenicSCORE: a simple tool for measuring cardiovascular disease risk. Hellenic J Cardiol. 2012; 53: 253-254.
11. Panagiotakos D. Health measurement scales: methodological issues. Open Cardiovasc Med J. 2009; 3: 160-165.
12. Pitsavos C, Panagiotakos DB, Chrysohoou C, Stefanadis C. Epidemiology of cardiovascular risk factors in Greece; aims, design and baseline characteristics of the ATTICA study. BMC Public Health 2003; 3: 32.
13. World Health Organization, mortality data statistics. Available from: http://www3.who.int/whosis/mort/table1.cfm?path=whosis,mort,mort_table1&language=english [accessed February 10, 2006]
14. D’Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001; 286: 180-187.
15. Panagiotakos DB, Stavrinos V. Methodological issues in cardiovascular epidemiology: the risk of determining absolute risk through statistical models. Vasc Health Risk Manag. 2006; 2: 309-315.
16. Graham IM, Cooney MT, Dudina A, Squarta S. What is my risk of developing cardiovascular disease? Eur J Cardiovasc Prev Rehabil. 2009; 16 Suppl 2: S2-7.
17. Elisaf M, Tzouvelekis E, Nikas N; Greek EURIKA Investigators. Primary prevention of cardiovascular disease in Greece: Greek results of the EURIKA study. Hellenic J Cardiol. 2014; 55: 217-226.
18. Donfrancesco C, Palmieri L, Cooney MT, et al. Italian cardiovascular mortality charts of the CUORE project: are they comparable with the SCORE charts? Eur J Cardiovasc Prev Rehabil. 2010; 17: 403-409.
19. Vardas PE. Cardiovascular medicine in 2025: assessments and priorities. Hellenic J Cardiol. 2012; 53: 171.
20. De Backer G, Graham I, Cooney MT. Do novel biomarkers add to existing scores of total cardiovascular risk? Eur J Prev Cardiol. 2012; 19: 14-17.
21. Zannad F, De Backer G, Graham I, et al; ESC Working Group on CardioVascular Pharmacology and Drug Therapy. Risk stratification in cardiovascular disease primary prevention-scoring systems, novel markers, and imaging techniques. Fundam Clin Pharmacol. 2012; 26: 163-174.
22. Vlismas K, Panagiotakos DB, Pitsavos C, et al. The role of dietary and socioeconomic status assessment on the predictive ability of the HellenicSCORE. Hellenic J Cardiol. 2011; 52: 391-398.